MedPath

Annex™ Adjacent Level System for Treatment of Adjacent Level Disease

Completed
Conditions
Degenerative Disc Disease
Adjacent Level Disease
Registration Number
NCT02108249
Lead Sponsor
Spine Wave
Brief Summary

The purpose of this study is to evaluate the clinical, radiological, and surgical outcomes of the Annex™ Adjacent Level System for the treatment of adjacent level disease of the lumbar spine. The Annex™ Adjacent Level System is a spinal fixation system intended to be used with commercially available pedicle screw fixation systems in order to extend existing pedicle screw constructs. Subjects will be evaluated over a 2 year period and compared to historical control.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Men or women 18-85 years of age
  • Single level adjacent level segment disease (ALD) in the lumbar spine (L1-S1).
Exclusion Criteria
  • trauma, tumor, pseudoarthrosis, revision, or same-level recurrent stenosis
  • cervical fusion candidates
  • extraspinal cause of back pain
  • local or systemic infection
  • pregnant / able to become pregnant and not following a reliable contraceptive method
  • Severe osteoporosis or osteopenia
  • Morbid obesity defined as BMI > 40
  • Anatomy or other factors that prohibit safe surgical access to the surgical site
  • Allergy or sensitivity to any component of the treatment procedure
  • Inadequate tissue coverage over the operative site
  • Inadequate bone stock or bone quality
  • Fever or leukocytosis
  • Uncorrectable coagulopathy or hemorrhagic diathesis
  • Cardiopulmonary conditions that present prohibitive anesthesia risk
  • Neuromuscular disease or disorder
  • Mental illness
  • Has an active workman's compensation claim

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Surgical Complication rate compared to retrospective chart reviewWithin 30 days of treatment
% Improvement in Operative/Discharge parameters including surgical time and hospital staywithin 30 days after treatment
Secondary Outcome Measures
NameTimeMethod
% Improvement in Quality of Life using SF-36Up to 2 years post-treatment
% Patient Satisfaction with procedureUp to 2 years post-treatment
% Pain reduction on VASUp to 2 years post-treatment
% Improvement in Disability using ODIUp to 2 years post-treatment

Trial Locations

Locations (1)

Carolinas Neurosurgery and Spine

🇺🇸

Charlotte, North Carolina, United States

Carolinas Neurosurgery and Spine
🇺🇸Charlotte, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.